Can cancer patients get better care at home? MD anderson investigates
NCT ID NCT05904899
First seen Jun 27, 2026 · Last updated Aug 14, 2026 · Updated 1 time
Summary
This study aims to understand the experiences of cancer patients who receive care at home through MD Anderson's Care and Monitoring at Home program. Researchers will use surveys to measure quality of life and gather feedback from up to 40 participants. The goal is to learn whether this home-based approach works well and how it might be improved.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this could show that home-based acute care is a viable option for cancer patients, potentially improving quality of life and reducing hospital stays.
- What could go wrong
- This is a small, observational study (40 participants) that is currently suspended. It only gathers feedback, not treatment outcomes, so results may not apply broadly.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 40 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Aug 2023
- Expected to finish
-
Dec 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Participants enrolled in the Care and Monitoring at Home program at MD Anderson.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Participants will be eligible for enrollment in this study if they have accepted enrollment in CaMH. No patients will be excluded if they are enrolled in CaMH. * Cognitively impaired adults will be able to participate in the study if an adults proxy provides informed consent and completes survey materials on their behalf. Exclusion Criteria: \- Children and pregnant women will not be enrolled in the CaMH program, and therefore not eligible for this study.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Cancer are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
The full official record for this study. This one lists no contact details, but it is the first place any would appear.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
MD Anderson Cancer Center
Houston, Texas, 77030, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Gut bacteria may hold clues to dozens of diseases
- Can a gentler blood thinner shield cancer patients from new clots?
- Can more phone calls after cancer surgery keep patients out of the hospital?
- Live music meets virtual reality: can a Three-Session program reach advanced cancer patients in palliative care?
- Can colorectal surgery patients go home in two days?
- Can a personal navigator help young cancer patients through treatment?